Insights on PRAME and osteosarcoma by means of gene expression profiling

Journal of Orthopaedic Science

Volumn 16, Issue 4, 2011, Pages 458-466

  Toledo, Sílvia Regina Caminada ^a   Zago, Marco Antonio ^b   Oliveira, Indhira Dias ^a   Proto Siqueira, Rodrigo ^b   Okamoto, Oswaldo K ^b   Severino, Patricia ^c   Vêncio, Ricardo Z N ^b   Gamba, Francine Tesser ^a   Silva, Wilson A ^b   Moreira Filho, Carlos A ^b   Torre, Cristiane A Dalla ^a   Alves, Maria Tereza Seixas ^a   Garcia Filho, Reynaldo J ^a   Simpson, Andrew J G ^d   Petrilli, Antonio Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Albert Einstein Research and Education Institute   (Brazil)

^d Ludwig Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR ANTIGEN; TUMOR MARKER;

ACCURACY; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL ADHESION; CHILD; CONTROLLED STUDY; EPITHELIAL CELL ADHESION MOLECULE GENE; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; OSTEOSARCOMA; PREFERENTIALLY EXPRESSED IN MELANOMA GENE; PRESCHOOL CHILD; TRANSCRIPTION INITIATION; TUMOR GENE;

EID: 80052513398     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-011-0106-7     Document Type: Article

References (30)

1. AF Kirkin K Dzhandzhugazyan J Zeuthen 1998 Melanoma-associated antigens recognized by cytotoxic T lymphocytes Apmis. 106 665 679 9740504 10.1111/j.1699-0463.1998.tb00210.x 1:CAS:528:DyaK1cXlslyltrk%3D (Pubitemid 28383441)
2. MJ Scanlan AO Gure AA Jungbluth LJ Old Y-T Chen 2002 Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol Rev 188 22 32 12445278 10.1034/j.1600-065X.2002.18803.x 1:CAS:528: DC%2BD38Xps1Oqsr4%3D (Pubitemid 35398862)
3. H Ikeda B Lethé F Lehmannn N van Baren JF Baurain C De Smet 1997 Caracterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity. 6 199 208 9047241 10.1016/S1074-7613(00)80426-4 1:CAS:528:DyaK2sXhsFaisbk%3D (Pubitemid 27145564)
4. N van Baren H Chambost A Ferrant L Michalex II Ikeda I Millard D Olive T Boon PG Collie 1998 PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukemia cells Br J Haematol. 102 1376 1379 9753074 10.1046/j.1365-2141.1998.00982.x (Pubitemid 28435230)
5. Wang MG, Zakut R, Yi H, Rosenberg S, McBride OW. Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28. Cytogenet Cell Genet. 1994;67(2):116-9. (Pubitemid 24213858)
6. Simpson AJG, Caballero OL, Jungbluth A, Chen Y-T, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(8):615-25. (Pubitemid 41081387)
7. MT Epping L Wang MJ Edel L Carlee M Hernandez R Bernards 2005 The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling Cell 122 835 847 16179254 10.1016/j.cell.2005.07.003 1:CAS:528: DC%2BD2MXhtVOrurnK (Pubitemid 41345202)
8. MT Epping R Bernards 2006 A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer Cancer Res 66 22 10639 10642 17108098 10.1158/0008-5472.CAN-06-2522 1:CAS:528:DC%2BD2sXivVyqsrc%3D (Pubitemid 44876955)
9. L Altucci H Gronemeyer 2001 The promise of retinoids to fight against cancer Nat Rev Cancer 1 181 193 11902573 10.1038/35106036 1:CAS:528: DC%2BD38XlvF2qtrw%3D (Pubitemid 33741893)
10. JFM Jacobs F Brasseur C Hulsbergen-van de Kaa MWMM van de Rakt CG Figdor GJ Adema PM Hoogerbrugge PG Coulie IJM de Vries, et al. 2006 Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR Int J Cancer 120 67 74 10.1002/ijc.22118
11. Jacobs JF, Grauer OM, Brasseur F, Hoogerbrugge PM, Wesseling P, Gidding CE, van de Rakt MW, Figdor CG, Coulie PG, de Vries IJ, Adema GJ. Selective cancer-germline gene expression in pediatric brain tumors. J Neurooncol. 2008;88:273-80.
12. PA Meyers R Gorlick 1997 Osteosarcoma Pediatr Clin North Am 44 973 989 9286295 10.1016/S0031-3955(05)70540-X 1:STN:280:DyaK2svjt1eqtA%3D%3D (Pubitemid 27368674)
13. SS Bielack B Kempf-Bielack G Delling GU Exner S Flege K Helmke R Kotz M Salzer-Kuntschik M Werner W Winkelmann A Zoubek H Jürgens K Winkler, et al. 1702 Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of patients treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols J Clin Oncol 2002 20 776 790
14. G Bacci F Bertoni A Longhi S Ferrari C Forni R Biagini P Bacchini D Donati M Manfrini G Bernini S Lari 2003 Neoadjvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor Cancer. 97 3068 3075 12784343 10.1002/cncr.11456 1:CAS:528:DC%2BD3sXlt1Shu7o%3D (Pubitemid 36676262)
15. Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Péricles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E, Brazilian Osteosarcoma Treatment Group Studies III and IV. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol. 2006;24:1161-8. (Pubitemid 46638814)
16. R Gorlick 2002 Osteosarcoma: clinical practice and the expanding role of biology J Musculoskel Neuron Interact. 2 549 551 1:STN:280: DC%2BD2M7islKmsg%3D%3D (Pubitemid 36157600)
17. RZ Vêncio DF Patrão CS Baptista CA Pereira B Zingales 2006 BayBoots: a model-free Bayesian tool to identify class markers from gene expression data Genet Mol Res 5 1 138 142 16755505
18. SA Rosenberg 2001 Progress in human tumour immunology and immunotherapy Nature. 411 380 384 11357146 10.1038/35077246 1:CAS:528:DC%2BD3MXktVSjs70%3D (Pubitemid 32467048)
19. C De Smet C Lurquin B Lethe V Martelange T Boon 1999 DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Mol Cell Biol 19 7327 7335 10523621 (Pubitemid 29493396)
20. C De Smet O De Backer I Faraoni C Lurquin F Brasser T Boon 1996 The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation Proc Natl Acad Sci USA 93 7149 7153 8692960 10.1073/pnas.93.14. 7149 (Pubitemid 26243517)
21. T Sudo T Kuramoto S Komiya A Inoune K Itoh 1997 Expression of MAGE genes in osteosarcoma J Orthop Res 15 1 128 132 9066537 10.1002/jor.1100150119 1:CAS:528:DyaK2sXitFejtb4%3D (Pubitemid 27111211)
22. Sigalotti L, Coral S, Altomonte M, Natali L, Gaudino G, Cacciotti P, Libener R, Colizzi F, Vianale G, Martini F, Tognon M, Jungbluth A, Cebon J, Maraskovsky E, Mutti L, Maio M. Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer. 2002;18;86(6):979-82. (Pubitemid 34271036)
23. Y Hosomi A Gemma Y Hosoya M Nara T Okano K Takenaka A Yoshimura K Koizumi K Shimizu S Kudoh 2003 Somatic mutation of the Caspase-5 gene in human lung cancer Int J Mol Med 12 4 443 446 12964016 1:CAS:528:DC%2BD3sXovFGgsL0%3D
24. K Maaser J Borlak, et al. 2008 A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators Br J Cancer 99 10 1635 1643 19002182 10.1038/sj.bjc.6604725 1:CAS:528:DC%2BD1cXhtlGrurzF
25. L Elia C Mennuni M Storto S Podda F Calvaruso V Salucci L Aurisicchio A Scarito G Ciliberto N La Monica F Palombo 2006 Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers Eur J Immunol 36 5 1337 1349 16619291 10.1002/eji.200535514 1:CAS:528:DC%2BD28Xlt1eku74%3D
26. PA Bauerle O Giris 2007 EpCAM (CD326) finding its role in cancer Br J Cancer. 96 417 423 10.1038/sj.bjc.6603494 (Pubitemid 46215211)
27. E Mariani A Meneghetti A Tarozzi L Cattini A Facchini 2000 Interleukin-12 induces efficient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells: the synergistic effect of interleukin-2 Scand J Immunol 51 6 618 625 10849374 10.1046/j.1365-3083.2000. 00737.x 1:CAS:528:DC%2BD3cXktlGgsb4%3D (Pubitemid 30353373)
28. P Zhang Y Yang PA Zweidler-McKay DP Hughes 2008 Critical role of notch signaling in osteosarcoma invasion and metastasis Clin Cancer Res 14 10 2962 2969 18483362 10.1158/1078-0432.CCR-07-1992 1:CAS:528:DC%2BD1cXmtVCmtLw%3D
29. M Tanaka T Setoguchi M Hirotsu H Gao H Sasaki Y Matsunoshita S Komiya 2009 Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation Br J Cancer 100 12 1957 1965 19455146 10.1038/sj.bjc.6605060 1:CAS:528:DC%2BD1MXntFygurw%3D
30. Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell. 1993;(9):953-61. (Pubitemid 23309430)